• 993 Citations
  • 15 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Lymphoma Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Neurology Chemical Compounds
Tumors Chemical Compounds
Neoplasms Medicine & Life Sciences
Osteopontin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 993 Citations
  • 15 h-Index
  • 50 Article

Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature

Dholaria, B. R., Kumar, A., Azzuqua, A. G., Nishihori, T., Kharfan-Dabaja, M. A., Tun, H. W. & Ayala, E., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Central Nervous System
Confidence Intervals
4 Citations (Scopus)

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

von Roemeling, C. A., Caulfield, T., Marlow, L., Bok, I., Wen, J., Miller, J. L., Hughes, R., Hazlehurst, L., Pinkerton, A. B., Radisky, D. C., Tun, H. W., Kim, Y. S. B., Lane, A. L. & Copland, J. A. III., Jan 1 2018, In : Oncotarget. 9, 1, p. 3-20 18 p.

Research output: Contribution to journalArticle

Stearoyl-CoA Desaturase
Drug Design
Enzyme Inhibitors
Drug Discovery

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience

Dholaria, B. R., Hammond, W. A., Roy, V., Sher, T., Vishnu, P., Soyano, A., Finn, L. E. & Tun, H. W., Mar 23 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle


Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models

Qiu, Y., Li, Z., Copland, J. A. III., Mehrling, T. & Tun, H. W., Jun 15 2018, In : Oncotarget. 9, 46, p. 28155-28164 10 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Brain Neoplasms
Central Nervous System
Triple Negative Breast Neoplasms

Pharmacokinetics-based clinical management of acquired von willebrand syndrome: A case report

Baldeo, C. M., Rivera, C. E., Tun, H. W. & Vishnu, P., Jan 19 2018, In : Journal of Blood Medicine. 9, p. 9-13 5 p.

Research output: Contribution to journalArticle

von Willebrand Factor
von Willebrand Diseases
Deamino Arginine Vasopressin
Type 1 von Willebrand Disease